Evidence map›Paper›PMID 33672995›Full record

ArticleInternational journal of molecular sciences2021

Investigation of Nanoparticle Metallic Core Antibacterial Activity: Gold and Silver Nanoparticles against

Jimmy Gouyau, Raphaël E Duval, Ariane Boudier, Emmanuel Lamouroux

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed
5.9field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed, 98 citations in OpenAlex.

  1. Life (Basel, Switzerland) · 2026
    Article
  2. Article
  3. Article
  4. Preparation of silibinin- dendrimer-stabilized Au nanoparticles for decreasing vancomycin resistance in S. aureus clinical isolates.International microbiology : the official journal of the Spanish Society for Microbiology · 2026
    Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. Article
  16. Article
  17. Review
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Jimmy GouyauUniversité de Lorraine, CNRS, L2CM, F-54000 Nancy, France.ORCID 0000-0003-2886-6036
Raphaël E DuvalUniversité de Lorraine, CNRS, L2CM, F-54000 Nancy, France.ORCID 0000-0003-4349-5595
Ariane BoudierUniversité de Lorraine, CITHEFOR, F-54000 Nancy, France.
Emmanuel LamourouxUniversité de Lorraine, CNRS, L2CM, F-54000 Nancy, France.ORCID 0000-0002-5987-8040
Centre National de la Recherche Scientifique · FRCibles thérapeutiques, formulation et expertise préclinique du médicament

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Multidrug-resistant (MDR) bacteria constitute a global health issue. Over the past ten years, interest in nanoparticles, particularly metallic ones, has grown as potential antibacterial candidates. However, as there is no consensus about the procedure to characterize the metallic nanoparticles (MNPs; i.e., metallic aggregates) and evaluate their antibacterial activity, it is impossible to conclude about their real effectiveness as a new antibacterial agent. To give part of the answer to this question, 12 nm gold and silver nanoparticles have been prepared by a chemical approach. After their characterization by transmission electronic microscopy (TEM), Dynamic Light Scattering (DLS), and UltraViolet-visible (UV-vis) spectroscopy, their surface accessibility was tested through the catalytic reduction of the 4-nitrophenol, and their stability in bacterial culture medium was studied. Finally, the antibacterial activities of 12 nm gold and silver nanoparticles facing

Indexed as

Anti-Bacterial AgentsDrug Resistance, Multiple, BacterialDynamic Light ScatteringEscherichia coliGoldMetal NanoparticlesMicrobial Sensitivity TestsMicroscopy, Electron, TransmissionSilverSpectrophotometryStaphylococcus aureusAnti-Bacterial AgentsGoldSilverantibacterial activitycharacterizationEscherichia coligoldmetallic nanoparticlesmultidrug resistant bacteriasilverstabilityStaphylococcus aureussurface reactivitysynthesis

Identifiers

PMID33672995
PMCPMC7918116
OpenAlexW3131450119

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.